MedPath

Effect of the Training Program on Balance, Function, Sense and Walking speed of Patients with Diabetic Neuropathy

Phase 3
Conditions
Diabetic Neuropathy.
????? ?? ????? ??????????
Registration Number
IRCT2017022231875N3
Lead Sponsor
Vice chancellor for research, Golestan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
44
Inclusion Criteria

Diabetes for at least 5 years; Diagnosis of Diabetic Peripheral Neuropathy with Score Greater than 2 by Michigan Neuropathy Screening Instrument (MNSI); Visual Acuity of 20/ 40 by Snellen Chart; Normal Range of Motion of the Hip, Knee and Ankle Joint; Ability to Stand and Walk; Independently and without Assistive Devices; Filling the Informed Consent Form.
Exclusion criteria: Foot Ulceration and Lower Limb Deformity; History of Surgery or Chronic Pain in the Lower Extremity or Low Back; History of Hypotension, Myocardial Infarction and Stroke; Other Peripheral Neurologic and Musculoskeletal Disorders; Using Drugs Effective on Balance during the Examination to Test.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Balance, motor function, proprioceptive sense and speed walking. Timepoint: before and 48 hours after end of the study. Method of measurement: Measurement of balance by Berg Balance Scale; Timed Up and Go test (TUG) for assessment of motor function; Using tuning fork for assessment of proprioceptive sense; and 25-Foot Walk Test (T25FW) for measurement of speed walking.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath